HYPERBARIC OXYGEN THERAPY

Urology

We provide Hyperbaric Oxygen Therapy (HBOT) as an evidence-based adjunctive treatment for select urological conditions, most notably radiation-induced injuries affecting the urinary and pelvic systems. Our focus is on supporting tissue recovery, symptom management, and improved quality of life for patients experiencing delayed effects of radiation therapy.

How Radiation Therapy Can Affect the Urological System

Radiation therapy, commonly used in the treatment of prostate and pelvic cancers, can lead to delayed radiation injuries that may appear months or even years after treatment. These injuries result from progressive tissue hypoxia, inflammation, fibrosis, and compromised blood supply.

Patients may experience symptoms such as:

Urinary Incontinence – Partial or complete loss of bladder control
Hematuria – Microscopic or visible blood in the urine
Dysuria – Pain or burning during urination
Pelvic, Bladder, or Rectal Pain – Due to radiation damage to surrounding tissues
Erectile Dysfunction – Resulting from vascular and nerve injury in the pelvic region

These symptoms may be associated with conditions such as radiation cystitis, radiation prostatitis, and radiation proctitis, all of which can significantly impact daily function and quality of life.

How HBOT Supports Healing of Radiation-Induced Urological Conditions

Hyperbaric Oxygen Therapy is FDA-approved for delayed radiation injuries and works by addressing the underlying pathophysiology of radiation damage. HBOT increases oxygen delivery to hypoxic tissues, supporting cellular repair and long-term healing.

HBOT may support recovery through the following mechanisms:

Enhanced Angiogenesis – HBOT stimulates the formation of new blood vessels, improving long-term oxygenation and nutrient delivery to radiation-damaged tissues.
Reduction of Inflammation and Edema –Increased oxygen availability helps decrease chronic inflammation, which may alleviate symptoms such as pain, urinary urgency, and dysuria.
Support of Fibroblast Activity and Collagen Remodeling – HBOT supports tissue repair while helping reduce abnormal fibrosis associated with radiation injury.
Improved Infection Response – By improving tissue oxygenation, HBOT may enhance host immune response and support the effectiveness of antibiotics in poorly perfused tissues.
Stem Cell Mobilization – HBOT has been shown to stimulate the release of stem cells from the bone marrow, supporting tissue regeneration and repair.

How Patients May Benefit from HBOT

While individual outcomes vary, patients undergoing HBOT for radiation-related urological conditions may experience:

Improved tissue healing and symptom stabilization
Reduction in pain, bleeding, and urinary irritation
Enhanced quality of life and daily function
A non-invasive, adjunctive treatment option that complements ongoing urologic care

HBOT is not a replacement for urologic management but serves as a supportive therapy within a comprehensive treatment plan coordinated with the patient’s referring physician.

Refer A Patient

Please submit the completed referral form along with supporting medical chart notes via fax to 480-590-6145.
For assistance with insurance coverage verification, our experienced team and insurance specialist, Isaac, is available at 619-861-8704 to help determine if your patient qualifies for coverage.
Call our office today at 480-590-5277 to get started.

We look forward to working with you!

Referral Form

Research & Studies

"Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up"

Research published in the Journal of Urology highlights the potential of Hyperbaric Oxygen Therapy (HBOT) in treating radiation-induced hemorrhagic cystitis. The study demonstrates that HBOT significantly improves symptoms, promotes healing of damaged bladder tissue, and enhances the quality of life for patients experiencing this condition. This underscores HBOT’s growing role as an effective adjunctive treatment in urological care, particularly for managing complications arising from radiation therapy. (Source: PubMed, https://pubmed.ncbi.nlm.nih.gov/18342453/)

"Hyperbaric oxygen for radiation-induced cystitis: A long-term follow-up"

A study published in the Journal of Urology explores the effectiveness of Hyperbaric Oxygen Therapy (HBOT) in managing radiation-induced cystitis. The research highlights significant symptom relief and improved bladder function among patients undergoing HBOT, emphasizing its therapeutic potential in promoting tissue healing and reducing complications associated with radiation damage. (Source: PubMed, https://pubmed.ncbi.nlm.nih.gov/32736899/)

"Radiation-induced cystitis and hyperbaric oxygen therapy"

A pivotal study published in The Lancet Oncology investigates the role of Hyperbaric Oxygen Therapy (HBOT) in treating late radiation-induced tissue injuries. The findings demonstrate that HBOT significantly improves healing and reduces symptoms in patients with radiation damage, particularly in tissues like the bladder and rectum. This reinforces HBOT as a valuable adjunct therapy for managing radiation-induced complications and enhancing quality of life. (Source: The Lancet Oncology, Abstract)

"Radiation Cystitis and Hyperbaric Management"

The comprehensive resource available on the National Center for Biotechnology Information outlines the clinical efficacy of Hyperbaric Oxygen Therapy (HBOT) across a variety of conditions, including chronic wounds, radiation injuries, and infections. It delves into the physiological mechanisms, such as enhanced oxygen delivery and angiogenesis, that underpin its therapeutic benefits. This foundational text serves as an essential guide for understanding the breadth of HBOT applications and its role in modern medical practice. (Source: NCBI, Full Text)

"Hyperbaric oxygen treatment for refractory haemorrhagic cystitis occurring after chemotherapy and haematopoietic stem cell transplantation: retrospective analysis of 25 patients"

A study published in Frontiers in Oncology highlights the efficacy of Hyperbaric Oxygen Therapy (HBOT) in managing genitourinary toxicity caused by radiation therapy for pelvic cancers. This comprehensive review emphasizes HBOT’s role in promoting tissue repair and alleviating symptoms such as hematuria, pain, and urinary dysfunction associated with radiation-induced cystitis. The findings underscore HBOT as a valuable therapeutic option, with evidence supporting its ability to improve patient outcomes and enhance quality of life. Further research is encouraged to optimize treatment protocols and expand its applications in radiation-related complications. For more details, visit: PMC Article

"Hyperbaric oxygen therapy for late radiation tissue injury"

Research published in Advances in Urology explores the role of Hyperbaric Oxygen Therapy (HBOT) in treating late radiation cystitis, a complication often experienced by patients undergoing radiation therapy for pelvic malignancies. The study demonstrates that HBOT can significantly reduce symptoms such as hematuria and bladder irritation by enhancing oxygen delivery to damaged tissues and promoting healing. This therapeutic approach offers a non-invasive and effective option for patients suffering from persistent genitourinary complications due to radiation therapy. For more information, visit: PMC Article

"Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis"

A study published in the Korean Journal of Urology highlights the effectiveness of Hyperbaric Oxygen Therapy (HBOT) in managing radiation-induced hemorrhagic cystitis. The research emphasizes that HBOT promotes tissue healing and reduces bleeding by increasing oxygen delivery to hypoxic tissues damaged by radiation. The findings suggest HBOT as a valuable treatment modality for patients experiencing persistent and severe symptoms of hemorrhagic cystitis following pelvic radiation therapy. For more details, visit: PMC Article